Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Riley Consumer Care Holdings
Riley Consumer Care Holdings
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zegerid
Bicarbonate,
Omeprazole
2009-12-01
2025-2042
Gastroesophageal reflux
,
Helicobacter infections
,
Stomach ulcer
,
Duodenal ulcer
,
Zollinger-ellison syndrome
,
Esophagitis
,
Heartburn
,
Rheumatoid arthritis
,
Pain
,
Fever
,
Inflammation
,
Osteoarthritis
,
Rheumatic fever
,
Gout
,
Urinary tract infections
,
Sinusitis
,
Nontuberculous mycobacterium infections
,
Otitis media
,
Bacterial infections
,
Infectious skin diseases
,
Bacterial skin diseases
,
Soft tissue infections
,
Mycoplasma pneumonia
,
Chlamydia infections
,
Bronchitis
,
Streptococcal infections
,
Tonsillitis
,
Lyme disease
,
Staphylococcal infections
,
Listeriosis
,
Haemophilus infections
,
Protozoan infections
,
Human bites
,
Actinomycosis
,
Pulmonary tuberculosis
,
Mycobacterium avium-intracellulare infection
,
Mycobacterium infections
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use